Back to the main directory
Press Release
- Xerium Awards Employment Inducement Award Pursuant to NYSE Rule 303A.08 by BusinessWire
- Rexnord Declares Dividend on Mandatory Convertible Preferred Stock by BusinessWire
- GM LOSS NOTICE: Rosen Law Firm Reminds General Motors Company Investors of Important Deadline in Class Action Filed by Firm - GM by BusinessWire
- Dreyfus Municipal Bond Infrastructure Fund, Inc. (NYSE:DMB) Announces Dividend by BusinessWire
- EnviroStar, Inc. to Acquire Martin-Ray Laundry Systems, Inc. by BusinessWire
- Viacom Announces the Pricing Terms of Its Cash Tender Offers for Certain Outstanding Debt Securities by BusinessWire
- SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of MOCON, Inc. Buyout by BusinessWire
- Amended Distribution Dates and Use of “Due-Bills†Announced for BlackRock Defined Opportunity Credit Trust’s Liquidating Distribution Declared on June 1, 2017 by BusinessWire
- CORRECTINGÂ and REPLACINGÂ Seagate to Participate in Investor Event by BusinessWire
- Kayne Anderson Energy Total Return Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at May 31, 2017 by BusinessWire
- Kayne Anderson Energy Development Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at May 31, 2017 by BusinessWire
- Luxoft to Demonstrate Financial Services & Automotive Solutions at PegaWorld 2017 by BusinessWire
- Wipro Annual Report 2017 on Form 20-F Available Online for ADS Holders by BusinessWire
- Anti-LAG-3 (BMS-986016) in Combination with Opdivo (nivolumab) Showed Activity in Patients with Melanoma Who Were Relapsed or Refractory to Anti-PD-1/PD-L1 Therapy by BusinessWire
- New Data Show Durability of Response for Merck’s KEYTRUDA® (pembrolizumab) in Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Solid Tumors, Regardless of Tumor Type by BusinessWire
- Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrated Promising Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer in Phase 2 CheckMate -142 Study by BusinessWire
- Combination of Epacadostat plus Keytruda® (pembrolizumab) Demonstrates Activity in Clinical Trial of Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) by BusinessWire
- Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies by BusinessWire
- UnitedHealthcare IRONKIDS Raleigh Fun Run Motivates Young People to Lead Active, Healthy Lifestyles by BusinessWire
- Pfizer Presents Final Phase 2 Data on Investigational PARP Inhibitor Talazoparib in Patients with Germline BRCA-Positive Advanced Breast Cancer by BusinessWire
- Assured Guaranty Files Adversary Complaint Challenging the Commonwealth of Puerto Rico’s Illegal Diversion of Special Revenue Bond Collateral by BusinessWire
- First Presentation of Efficacy Data from CheckMate -204 Evaluating the Combination of Opdivo (nivolumab) and Yervoy (ipilimumab) Demonstrates Anti-tumor Activity in Advanced Melanoma Patients with Brain Metastases by BusinessWire
- With More than One-Year Follow-Up, Merck’s KEYTRUDA® (pembrolizumab) Shows Continued Overall Survival Benefit Over Chemotherapy as Second-Line Treatment for Advanced Urothelial Carcinoma Patients Post-Platinum Failure by BusinessWire
- New Monotherapy Data for Merck’s KEYTRUDA® (pembrolizumab) in Heavily Pre-Treated Patients with Advanced Gastric Cancer to be Presented at 2017 ASCO Annual Meeting by BusinessWire
- Lincoln’s Mix of Vehicles Leads to Highest Loyalty Rating in Luxury Segment by BusinessWire
- European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for Previously Treated Locally Advanced Unresectable or Metastatic Urothelial Carcinoma in Adults After Failure of Prior Platinum-Containing Therapy by BusinessWire
- Packaging Corporation of America’s Chief Executive Officer to Speak at Vertical Research Partners’ Conference and BMO’s Forum in June by BusinessWire
- Equity Residential to Participate in NAREIT REIT Week 2017 Conference by BusinessWire
- Boston Properties Renews ATM Equity Offering Program by BusinessWire
- SecureWorks to Host Annual Meeting of Stockholders by BusinessWire
- Energy-Efficient LED Lighting Provider Orion to Hold FY 2017 Fourth Quarter Financial Results and Conference Call on Thursday, June 8 at 4:30 pm ET by BusinessWire
- Masimo et Mdoloris annoncent un partenariat Masimo Open Connect™ (MOC) pour Root®, la plateforme de connectivité et de suivi des patients by BusinessWire
- RealPage to Participate in Upcoming Investor Conference by BusinessWire
- International Banker Names Western Alliance’s Robert Sarver North America ‘Banking CEO of the Year’ for 2017 by BusinessWire
- Kayne Anderson Midstream/Energy Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at May 31, 2017 by BusinessWire
- Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at May 31, 2017 by BusinessWire
- CONN’S INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Conn's, Inc. - CONN by BusinessWire
- DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Investors with Losses in Excess of $100,000 from Investment in Lion Biotechnologies, Inc. to Contact the Firm by BusinessWire
- Longer Term Follow-Up Data with Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed and Carboplatin in First-Line Nonsquamous Metastatic Non-Small Cell Lung Cancer (NSCLC) to Be Presented at 2017 ASCO Annual Meeting by BusinessWire
- ArQule Presents Phase 1/2 Clinical Data with ARQ 087 in Intrahepatic Cholangiocarcinoma at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting by BusinessWire
- Combination of Incyte’s Epacadostat plus Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Activity in Clinical Trial of Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) by BusinessWire
- Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE Trial by BusinessWire
- Dollar General Celebrates Grand Opening in Janesville, Wisconsin, of its 14th Distribution Center by BusinessWire
- Puma Biotechnology Announces Positive PB272 Phase II Data from TBCRC 022 Trial in Patients with HER2-Positive Metastatic Breast Cancer with Brain Metastases at the 2017 ASCO Annual Meeting by BusinessWire
- Une combinaison d'epacadostat et de Keytruda® (pembrolizumab) fait état d'une activité dans un essai clinique pour les patients atteints de cancer du poumon non à petites cellules avancé (CPNPC) by BusinessWire
- LYNPARZAâ„¢ (olaparib) Significantly Reduces the Risk of Disease Worsening or Death in Patients with BRCA-Mutated Metastatic Breast Cancer by BusinessWire
- New Data Evaluating the Safety and Preliminary Relapse-Free Survival of Adjuvant Yervoy (ipilimumab) 3 mg/kg and 10 mg/kg in Resected High-Risk Melanoma Patients Presented at ASCO by BusinessWire
- Orbital ATK’s “S.S. John Glenn†Cygnus Departs International Space Station, Begins Secondary Mission in Space by BusinessWire
- Herbalife Nutrition Announces That in the Month of May 90% of Sales in the United States Were Documented Purchases by Consumers, Far in Excess of the 80% Threshold Called for in its Agreement With the U.S. Federal Trade Commission by BusinessWire
- Logitech Wins Record-Breaking Nine IDA 2016 Awards by BusinessWire